Indeed, co-culture of cancer cells that highly express CD19 resulted in marked AICD in CD19 CAR T cells, whereas CD19-ReTARGTPR-redirected anti-CMVpp65 CTLS achieved comparable target cell elimination with no or minimal AICD observed. The gene discussed is CD19; the disease is cancer.